サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1452570

欧州の蛍光In-Situハイブリダイゼーションイメージングシステム市場の2030年までの予測-地域別分析-製品別、用途別、エンドユーザー別

Europe Fluorescence In-Situ Hybridization Imaging Systems Market Forecast to 2030 - Regional Analysis - By Product, Application, and End User

出版日
ページ情報
英文 99 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
欧州の蛍光In-Situハイブリダイゼーションイメージングシステム市場の2030年までの予測-地域別分析-製品別、用途別、エンドユーザー別
出版日: 2024年01月05日
発行: The Insight Partners
ページ情報: 英文 99 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

欧州の蛍光In-Situハイブリダイゼーションイメージングシステム市場は、2022年の2億6,800万米ドルから2030年には4億6,070万米ドルに成長すると予測されています。2022年から2030年までのCAGRは7.0%と推定されます。

蛍光In-Situハイブリダイゼーションイメージングにおける技術的進歩が欧州の蛍光In-Situハイブリダイゼーションイメージングシステム市場に拍車をかける

蛍光In-Situハイブリダイゼーションイメージングシステムは、技術的進歩の急増により著しい進化を遂げており、その結果、最先端のイノベーションが遺伝子研究と診断の状況を一変させています。これらの進歩には、強化された光学系、より高感度で汎用性の高い蛍光色素、洗練された自動化機能などが含まれます。これらのアップグレードされた機能と統合された最新の蛍光In-Situハイブリダイゼーションイメージングシステムは、より高い感度、改善された画像解像度、より速い処理時間を提供します。さらに、これらの技術的進歩により、蛍光In-Situハイブリダイゼーションイメージングの応用範囲は、がん診断から遺伝的素因検査へと広がっています。2021年7月、BioViewとCapio Biosciencesは、全血から循環腫瘍細胞（CTC）を採取するためのプラットフォームを共同で開発しました。両社の技術を統合することで、両社はさらにCTCリキッドバイオプシーのダウンストリーム解析の改善に取り組みました。同様に、BioViewとCapio Biosciencesは共同で、2020年12月にRUBYnanomedと提携し、がん検出を強化するため、臨床におけるCTC技術の受容と採用を加速する独自のイメージングソリューションを開発しました。このように、蛍光In-Situハイブリダイゼーションイメージングシステムの技術的進歩は、蛍光In-Situハイブリダイゼーションイメージングシステム市場の企業にとって大きなビジネスチャンスを生み出しています。

欧州蛍光In-Situハイブリダイゼーションイメージングシステム市場概要

欧州の蛍光In-Situハイブリダイゼーションイメージングシステム市場は、ドイツ、英国、フランス、イタリア、スペイン、その他の欧州に区分されます。この地域は世界市場で大きなシェアを占めています。欧州の蛍光In-Situハイブリダイゼーションイメージングシステム市場は、強力な医療機器製造能力と異なる欧州諸国における高いがん有病率により、予測期間中に大きく成長することが期待されています。ドイツは世界で最も有利な医療機器市場の一つです。国際貿易局（ITA）によると、ドイツの医療機器市場は年間358億米ドル、欧州の医療機器市場全体の25.6%を占めています。ITAによると、ドイツは米国、日本に次いで世界第3位の医療技術市場であり、欧州では断トツの規模を誇る。

欧州最大の人口を抱えるドイツの医療セグメントは、大きな成長機会を持つ非常に魅力的なセグメントです。平均寿命の着実な伸びにより、がんや慢性疾患、加齢に関連する病気の患者が増加しています。世界銀行のデータによると、2022年にはドイツ人の約22％が65歳以上の高齢者となり、少なくとも1つの慢性疾患にかかる可能性があります。世界がん研究基金（WCRF）インターナショナルによると、ドイツのがん罹患率（年齢標準化）は10万人当たり281.9人で、2020年には53万8,140人となります。さらに、GLOBOCAN 2020によると、ドイツは乳がん、前立腺がん、肺がん、大腸がんの有病率が高いです。慢性疾患やがんの蔓延による健康意識の向上が、診断システムへの需要を高めています。このように、ドイツでは医療機器の研究開発が盛んであり、がん患者が増加していることから、蛍光In-Situハイブリダイゼーションイメージングシステムの採用が急増しています。

欧州の蛍光In-Situハイブリダイゼーションイメージングシステム市場の収益と2030年までの予測（金額）

欧州の蛍光In-Situハイブリダイゼーションイメージングシステム市場のセグメンテーション

欧州の蛍光In-Situハイブリダイゼーションイメージングシステム市場は、製品、用途、エンドユーザー、国にセグメント化されます。

製品別では、欧州の蛍光In-Situハイブリダイゼーションイメージングシステム市場は、機器、消耗品、付属品、ソフトウェアに区分されます。消耗品セグメントは、2022年の欧州蛍光In-Situハイブリダイゼーションイメージングシステム市場で最大のシェアを占めました。

用途別では、欧州の蛍光In-Situハイブリダイゼーションイメージングシステム市場は、がん診断、遺伝病診断、感染症診断、その他に区分されます。2022年の欧州蛍光In-Situハイブリダイゼーションイメージングシステム市場では、がん診断セグメントが最大のシェアを占めています。

エンドユーザーに基づき、欧州の蛍光In-Situハイブリダイゼーションイメージングシステム市場は、診断ラボ、契約研究機関、製薬・バイオテクノロジー企業、その他に区分されます。2022年の欧州蛍光In-Situハイブリダイゼーションイメージングシステム市場では、診断ラボセグメントが最大のシェアを占めています。

国別では、欧州蛍光In-Situハイブリダイゼーションイメージングシステム市場は、ドイツ、フランス、英国、イタリア、スペイン、その他の欧州に区分されます。2022年の欧州蛍光In-Situハイブリダイゼーションイメージングシステム市場はドイツが独占しています。

Euroclone SpA、TissueGnostics GmbH、Agilent Technologies Inc、Abnova Taiwan Corp、BioGenex Laboratories Inc、Leica Biosystems Nussloch GmbH、MetaSystems Probes GmbH、Bio-View Ltd、Thermo Fisher Scientific Inc、Applied Spectral Imagingは、欧州の蛍光In-Situハイブリダイゼーションイメージングシステム市場で事業展開している大手企業の一部です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要な洞察

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 欧州蛍光In-Situハイブリダイゼーションイメージングシステム市場-主要産業力学

  • 主要市場の促進要因
    • 対象疾患の有病率の上昇
    • 体外診断への研究開発投資の増加
  • 主要市場抑制要因
    • 蛍光In-Situハイブリダイゼーションイメージングシステムと手順の高コスト
  • 主要市場機会
    • 蛍光In-Situハイブリダイゼーションイメージングの技術進歩
  • 今後の動向
    • 蛍光In-Situハイブリダイゼーションイメージング技術の自動化とデジタル化
  • 影響分析

第5章 蛍光In-Situハイブリダイゼーションイメージングシステム市場-欧州市場分析

  • 欧州の蛍光In-Situハイブリダイゼーションイメージングシステム市場収益、2022～2030年

第6章 欧州蛍光In-Situハイブリダイゼーションイメージングシステム市場～2030年までの収益と予測：製品別

  • イントロダクション
  • 欧州蛍光In-Situハイブリダイゼーションイメージングシステム市場：2022年・2030年売上高シェア（%）：製品別
  • 機器
  • 消耗品
  • 付属品
  • ソフトウェア

第7章 欧州蛍光In-Situハイブリダイゼーションイメージングシステム市場：収益と2030年までの予測：用途別

  • イントロダクション
  • 欧州蛍光In-Situハイブリダイゼーションイメージングシステム市場：2022年・2030年売上高シェア（%）：用途別
  • がん診断
  • 遺伝子疾患診断
  • 感染症診断
  • その他

第8章 欧州蛍光In-Situハイブリダイゼーションイメージングシステム市場：収益と2030年までの予測：エンドユーザー別

  • イントロダクション
  • 欧州蛍光In-Situハイブリダイゼーションイメージングシステム市場2022年・2030年売上高シェア（%）：エンドユーザー別
  • 診断ラボ
  • 契約研究機関
  • 製薬・バイオテクノロジー企業
  • その他

第9章 欧州蛍光In-Situハイブリダイゼーションイメージングシステム市場：国別分析

  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他の欧州

第10章 欧州蛍光In-Situハイブリダイゼーションイメージングシステム市場業界情勢

  • イントロダクション
  • 欧州蛍光In-Situハイブリダイゼーションイメージングシステム市場の成長戦略
  • 無機的成長戦略
  • 有機的成長戦略

第11章 企業プロファイル

  • Euroclone SpA
  • TissueGnostics GmbH
  • Agilent Technologies Inc
  • Leica Biosystems Nussloch GmbH
  • MetaSystems Probes GmbH
  • Thermo Fisher Scientific Inc
  • PerkinElmer Inc

第12章 付録

図表

List Of Tables

  • Table 1. Instruments: Europe Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
  • Table 2. Consumables: Europe Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. Germany Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Product- Revenue and Forecast to 2030 (US$ Million)
  • Table 4. Germany Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Instruments - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. Germany Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Consumables - Revenue and Forecast to 2030 (US$ Million)
  • Table 6. Germany Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. Germany Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 8. UK Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Product- Revenue and Forecast to 2030 (US$ Million)
  • Table 9. UK Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Instruments - Revenue and Forecast to 2030 (US$ Million)
  • Table 10. UK Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Consumables - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. UK Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 12. UK Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 13. France Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Product- Revenue and Forecast to 2030 (US$ Million)
  • Table 14. France Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Instruments - Revenue and Forecast to 2030 (US$ Million)
  • Table 15. France Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Consumables - Revenue and Forecast to 2030 (US$ Million)
  • Table 16. France Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 17. France Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 18. Italy Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Product- Revenue and Forecast to 2030 (US$ Million)
  • Table 19. Italy Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Instruments - Revenue and Forecast to 2030 (US$ Million)
  • Table 20. Italy Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Consumables - Revenue and Forecast to 2030 (US$ Million)
  • Table 21. Italy Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 22. Italy Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 23. Spain Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Product- Revenue and Forecast to 2030 (US$ Million)
  • Table 24. Spain Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Instruments - Revenue and Forecast to 2030 (US$ Million)
  • Table 25. Spain Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Consumables - Revenue and Forecast to 2030 (US$ Million)
  • Table 26. Spain Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 27. Spain Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 28. Rest of Europe Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Product- Revenue and Forecast to 2030 (US$ Million)
  • Table 29. Rest of Europe Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Instruments - Revenue and Forecast to 2030 (US$ Million)
  • Table 30. Rest of Europe Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Consumables - Revenue and Forecast to 2030 (US$ Million)
  • Table 31. Rest of Europe Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 32. Rest of Europe Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by End User - Revenue and Forecast to 2030 (US$ Million)

List Of Figures

  • Figure 1. Europe Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Segmentation
  • Figure 2. Europe Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Segmentation, By Country
  • Figure 3. Europe Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Key Industry Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. Europe Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Revenue (US$ Mn), 2022 - 2030
  • Figure 6. Europe Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Revenue Share, by Product 2022 & 2030 (%)
  • Figure 7. Instruments: Europe Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Consumables: Europe Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Accessories: Europe Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Software: Europe Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Europe Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Revenue Share, by Application 2022 & 2030 (%)
  • Figure 12. Cancer Diagnosis: Europe Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Genetic Disease Diagnosis: Europe Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Infectious Disease Diagnosis: Europe Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Others: Europe Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Europe Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Revenue Share, by End User 2022 & 2030 (%)
  • Figure 17. Diagnostic Laboratories: Europe Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Contract Research Organization: Europe Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Pharmaceutical and Biotechnological Companies: Europe Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Others: Europe Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Europe Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, By Country, 2022 ($Mn)
  • Figure 22. Europe Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, By Key Countries, 2022 And 2030 (%)
  • Figure 23. Germany Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 24. UK Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 25. France Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 26. Italy Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 27. Spain Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 28. Rest of Europe Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 29. Growth Strategies in the Europe Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market
  • Figure 30. Recent Inorganic Growth Strategies in the Europe Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market
  • Figure 31. Recent Organic Growth Strategies in the Europe Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market
  • Figure 32. Glossary of Terms, Europe Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market
目次
Product Code: BMIRE00029261

The Europe fluorescence in-situ hybridization (FISH) imaging systems market is expected to grow from US$ 268.0 million in 2022 to US$ 460.7 million by 2030. It is estimated to grow at a CAGR of 7.0% from 2022 to 2030.

Technological Advancements in Fluorescence in Situ Hybridization Imaging Fuel Europe Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market

FISH imaging systems are witnessing a remarkable evolution due to the surge in technological advancements, which result in cutting-edge innovations transforming the landscape of genetic research and diagnostics. These advancements include enhanced optics, more sensitive and versatile fluorophores, and sophisticated automation features. Modern FISH imaging systems, integrated with these upgraded features, offer greater sensitivity, improved image resolution, and faster processing times. Moreover, these technological advancements have extended the application scope of FISH imaging from cancer diagnosis to genetic predisposition testing. In July 2021, BioView and Capio Biosciences collaborated to create a platform for collecting circulating tumor cells (CTCs) from whole blood. By integrating their technologies, these companies further worked on improving the CTC liquid biopsy downstream analysis. Similarly, BioView and Capio Biosciences, in collaboration, partnered with RUBYnanomed in December 2020 to create a unique imaging solution to accelerate the acceptance and adoption of CTC technology in clinics to enhance cancer detection. Thus, technological advancements in FISH imaging systems create significant opportunities for companies in the fluorescence in situ hybridization (FISH) imaging systems market.

Europe Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Overview

The Europe fluorescence in-situ hybridization (FISH) imaging systems market in Europe is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. The region holds a significant share of the global market. The European Europe Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market is expected to grow significantly during the forecast period due to the strong medical device manufacturing capabilities and high cancer prevalence in different European countries. Germany is one of the most lucrative medical device markets across the world. According to International Trade Administration (ITA), the German medical device market accounts for ~US$ 35.8 billion annually or 25.6% of the total European medical device market. As per ITA, Germany is the third-largest medical technology market in the world after the US and Japan and is by far the largest European market.

Catering to the largest population in Europe, Germany's healthcare sector is a highly attractive sector with significant growth opportunities. A steady increase in life expectancy levels has led to a rise in cases of cancer and chronic and age-related illnesses. According to the data from The World Bank, in 2022, approximately 22% of Germans are aged 65 and above and prone to at least one chronic disease; this percentage is slightly higher than in any other European country. According to World Cancer Research Fund (WCRF) International, Germany had a significant incidence age-standardized rate of 281.9 cancer cases per 100,000, with 538,140 new cases in 2020. Additionally, as per GLOBOCAN 2020, Germany has a high prevalence rate of breast, prostate, lung, and colorectum cancer. Improved health awareness due to the prevalence of chronic diseases and cancer has increased the demand for diagnostics systems. Thus, the adoption of fluorescence in-situ hybridization (FISH) imaging systems is growing rapidly in Germany due to the flourishing medical device R&D landscape and rising cancer cases.

Europe Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Revenue and Forecast to 2030 (US$ Million)

Europe Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Segmentation

The Europe fluorescence in-situ hybridization (FISH) imaging systems market is segmented into product, application, end users and country.

Based on product, the Europe fluorescence in-situ hybridization (FISH) imaging systems market is segmented into instruments, consumables, accessories, and software. The consumables segment held the largest share of the Europe fluorescence in-situ hybridization (FISH) imaging systems market in 2022.

In terms of application, the Europe fluorescence in-situ hybridization (FISH) imaging systems market is segmented into cancer diagnosis, genetic disease diagnosis, infectious disease diagnostic, and others. The cancer diagnosis segment held the largest share of the Europe fluorescence in-situ hybridization (FISH) imaging systems market in 2022.

Based on end user, the Europe fluorescence in-situ hybridization (FISH) imaging systems market is segmented into diagnostic laboratories, contract research organizations, pharmaceutical and biotechnological companies, and others. The diagnostic laboratories segment held the largest share of the Europe fluorescence in-situ hybridization (FISH) imaging systems market in 2022.

By country, the Europe fluorescence in-situ hybridization (FISH) imaging systems market is segmented int o Germany, France, the UK, Italy, Spain, and the Rest of Europe. Germany dominated the Europe fluorescence in-situ hybridization (FISH) imaging systems market in 2022.

Euroclone SpA, TissueGnostics GmbH, Agilent Technologies Inc, Abnova Taiwan Corp, BioGenex Laboratories Inc, Leica Biosystems Nussloch GmbH, MetaSystems Probes GmbH, Bio-View Ltd, Thermo Fisher Scientific Inc, and Applied Spectral Imaging are some of the leading companies operating in the Europe fluorescence in-situ hybridization (FISH) imaging systems market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Europe Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Key Industry Dynamics

  • 4.1 Key Market Drivers:
    • 4.1.1 Rising Prevalence of Target Disorders
    • 4.1.2 Increasing R&D Investments in In-Vitro Diagnostics
  • 4.2 Key Market Restraints:
    • 4.2.1 High Cost of FISH Imaging Systems and Procedures
  • 4.3 Key Market Opportunities:
    • 4.3.1 Technological Advancements in Fluorescence in Situ Hybridization Imaging
  • 4.4 Future Trends:
    • 4.4.1 Automation and Digitalization of FISH Imaging Technique
  • 4.5 Impact Analysis:

5. Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Europe Market Analysis

  • 5.1 Europe Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Revenue (US$ Mn), 2022 - 2030

6. Europe Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 - by Product

  • 6.1 Overview
  • 6.2 Europe Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Revenue Share, by Product 2022 & 2030 (%)
  • 6.3 Instruments
    • 6.3.1 Overview
    • 6.3.2 Instruments: Europe Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.4 Consumables
    • 6.4.1 Overview
    • 6.4.2 Consumables: Europe Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.5 Accessories
    • 6.5.1 Overview
    • 6.5.2 Accessories: Europe Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.6 Software
    • 6.6.1 Overview
    • 6.6.2 Software: Europe Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)

7. Europe Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 - by Application

  • 7.1 Overview
  • 7.2 Europe Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Revenue Share, by Application 2022 & 2030 (%)
  • 7.3 Cancer Diagnosis
    • 7.3.1 Overview
    • 7.3.2 Cancer Diagnosis: Europe Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Genetic Disease Diagnosis
    • 7.4.1 Overview
    • 7.4.2 Genetic Disease Diagnosis: Europe Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Infectious Disease Diagnosis
    • 7.5.1 Overview
    • 7.5.2 Infectious Disease Diagnosis: Europe Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Others
    • 7.6.1 Overview
    • 7.6.2 Others: Europe Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 - by End User

  • 8.1 Overview
  • 8.2 Europe Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Revenue Share, by End User 2022 & 2030 (%)
  • 8.3 Diagnostic Laboratories
    • 8.3.1 Overview
    • 8.3.2 Diagnostic Laboratories: Europe Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Contract Research Organization
    • 8.4.1 Overview
    • 8.4.2 Contract Research Organization: Europe Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Pharmaceutical and Biotechnological Companies
    • 8.5.1 Overview
    • 8.5.2 Pharmaceutical and Biotechnological Companies: Europe Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Others
    • 8.6.1 Overview
    • 8.6.2 Others: Europe Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market - Country Analysis

  • 9.1 Europe Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, Revenue and Forecast to 2030
    • 9.1.1 Overview
    • 9.1.2 Europe Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market by Country
      • 9.1.2.1 Germany
        • 9.1.2.1.1 Overview
        • 9.1.2.1.2 Germany Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.2.1.3 Germany: Europe Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Product, 2020-2030 (US$ Million)
        • 9.1.2.1.3.1 Germany: Europe Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Instruments, 2020-2030 (US$ Million)
        • 9.1.2.1.3.2 Germany: Europe Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Consumables, 2020-2030 (US$ Million)
        • 9.1.2.1.4 Germany: Europe Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Application, 2020-2030 (US$ Million)
        • 9.1.2.1.5 Germany: Europe Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by End User, 2020-2030 (US$ Million)
      • 9.1.2.2 UK
        • 9.1.2.2.1 Overview
        • 9.1.2.2.2 UK Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.2.2.3 UK Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Product, 2020-2030 (US$ Million)
        • 9.1.2.2.3.1 UK Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Instruments, 2020-2030 (US$ Million)
        • 9.1.2.2.3.2 UK Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Consumables, 2020-2030 (US$ Million)
        • 9.1.2.2.4 UK Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Application, 2020-2030 (US$ Million)
        • 9.1.2.2.5 UK Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by End User, 2020-2030 (US$ Million)
      • 9.1.2.3 France
        • 9.1.2.3.1 Overview
        • 9.1.2.3.2 France Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.2.3.3 France Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Product, 2020-2030 (US$ Million)
        • 9.1.2.3.3.1 France Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Instruments, 2020-2030 (US$ Million)
        • 9.1.2.3.3.2 France Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Consumables, 2020-2030 (US$ Million)
        • 9.1.2.3.4 France Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Application, 2020-2030 (US$ Million)
        • 9.1.2.3.5 France Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by End User, 2020-2030 (US$ Million)
      • 9.1.2.4 Italy
        • 9.1.2.4.1 Overview
        • 9.1.2.4.2 Italy Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.2.4.3 Italy Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Product, 2020-2030 (US$ Million)
        • 9.1.2.4.3.1 Italy Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Instruments, 2020-2030 (US$ Million)
        • 9.1.2.4.3.2 Italy Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Consumables, 2020-2030 (US$ Million)
        • 9.1.2.4.4 Italy Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Application, 2020-2030 (US$ Million)
        • 9.1.2.4.5 Italy Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by End User, 2020-2030 (US$ Million)
      • 9.1.2.5 Spain
        • 9.1.2.5.1 Overview
        • 9.1.2.5.2 Spain Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.2.5.3 Spain Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Product, 2020-2030 (US$ Million)
        • 9.1.2.5.3.1 Spain Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Instruments, 2020-2030 (US$ Million)
        • 9.1.2.5.3.2 Spain Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Consumables, 2020-2030 (US$ Million)
        • 9.1.2.5.4 Spain Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Application, 2020-2030 (US$ Million)
        • 9.1.2.5.5 Spain Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by End User, 2020-2030 (US$ Million)
      • 9.1.2.6 Rest of Europe
        • 9.1.2.6.1 Overview
        • 9.1.2.6.2 Rest of Europe Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.2.6.3 Rest of Europe Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Product, 2020-2030 (US$ Million)
        • 9.1.2.6.3.1 Rest of Europe Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Instruments, 2020-2030 (US$ Million)
        • 9.1.2.6.3.2 Rest of Europe Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Consumables, 2020-2030 (US$ Million)
        • 9.1.2.6.4 Rest of Europe Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by Application, 2020-2030 (US$ Million)
        • 9.1.2.6.5 Rest of Europe Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market, by End User, 2020-2030 (US$ Million)

10. Europe Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market Industry Landscape

  • 10.1 Overview
  • 10.2 Growth Strategies in the Europe Fluorescence In-Situ Hybridization (FISH) Imaging Systems Market
  • 10.3 Inorganic Growth Strategies
    • 10.3.1 Overview
  • 10.4 Organic Growth Strategies
    • 10.4.1 Overview

11. Company Profiles

  • 11.1 Euroclone SpA
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Products and Services
    • 11.1.4 Financial Overview
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 TissueGnostics GmbH
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Products and Services
    • 11.2.4 Financial Overview
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 Agilent Technologies Inc
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Products and Services
    • 11.3.4 Financial Overview
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4 Leica Biosystems Nussloch GmbH
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.3 Products and Services
    • 11.4.4 Financial Overview
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Developments
  • 11.5 MetaSystems Probes GmbH
    • 11.5.1 Key Facts
    • 11.5.2 Business Description
    • 11.5.3 Products and Services
    • 11.5.4 Financial Overview
    • 11.5.5 SWOT Analysis
    • 11.5.6 Key Developments
  • 11.6 Thermo Fisher Scientific Inc
    • 11.6.1 Key Facts
    • 11.6.2 Business Description
    • 11.6.3 Products and Services
    • 11.6.4 Financial Overview
    • 11.6.5 SWOT Analysis
    • 11.6.6 Key Developments
  • 11.7 PerkinElmer Inc
    • 11.7.1 Key Facts
    • 11.7.2 Business Description
    • 11.7.3 Products and Services
    • 11.7.4 Financial Overview
    • 11.7.5 SWOT Analysis
    • 11.7.6 Key Developments

12. Appendix

  • 12.1 About Us
  • 12.2 Glossary of Terms